Market News AIOpen the app

Guardian Pharmacy Service held a call to discuss its earnings for the second quarter of 2026.

ResultsRead the original at Benzinga
Good for GRDN

Guardian Pharmacy Service's adjusted EBITDA grew 23%, gross profit rose 18%, and it raised its 2026 forecast. Reported sales grew 2% amid IRA price cuts, but profit growth and the higher forecast point to improving results.

GRDN · Guardian Pharmacy Service

AI read · Good for GRDN

The AI's read

Profit grew faster than sales, suggesting Guardian protected its operations as IRA price cuts squeezed reported sales. It also raised its full-year forecast. Reported sales grew 2%, while adjusted EBITDA, a measure of operating profit, grew 23% and gross profit rose 18%. Guardian said sales would have grown at a low double-digit rate without the price cuts. Expansion includes the Wellness Concepts acquisition and a new Lexington pharmacy. These steps support its growth plans, but their future contribution is not yet shown in these results.

Get alerts for GRDN

Follow Guardian Pharmacy Service (GRDN) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for GRDN
Free on the App Store and Google Play, or on the web.